SEYJUNA

Serial Number 98200486
Registration 7718534
700

Registration Progress

Application Filed
Sep 27, 2023
Under Examination
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered
Mar 11, 2025

Trademark Image

SEYJUNA

Basic Information

Serial Number
98200486
Registration Number
7718534
Filing Date
September 27, 2023
Registration Date
March 11, 2025
Published for Opposition
January 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 11, 2025
Registration
Registered
Classes
005

Rights Holder

Rosemont Pharmaceuticals Limited

99
Address
Rosemont House, Yorkdale Industrial Park
Braithwaite Street
Leeds LS119XE

Ownership History

Rosemont Pharmaceuticals Limited

Original Applicant
99
Leeds

Rosemont Pharmaceuticals Limited

Owner at Publication
99
Leeds

Rosemont Pharmaceuticals Limited

Original Registrant
99
Leeds

Legal Representation

Attorney
Mark C. Reichel

USPTO Deadlines

Next Deadline
2067 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-11)
Due Date
March 11, 2031
Grace Period Ends
September 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description
Mar 11, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 11, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 24, 2024 ALIE A ASSIGNED TO LIE
Oct 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2024 DOCK D ASSIGNED TO EXAMINER
May 20, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2024 GNRT F NON-FINAL ACTION E-MAILED
May 20, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 11, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...